Department of Neurodegenerative Science
46 results.
GRAND RAPIDS, Mich. (April 16, 2024) — A new study from Van Andel Institute scientists offers a first look into the complex molecular changes that occur…
GRAND RAPIDS, Mich. (April 11, 2024) — Van Andel Institute has named pioneering scientist Anders Björklund, M.D., Ph.D., as recipient of its 2024
LONDON (April 3, 2024) — Results from a one-year, phase 2 clinical trial of the Type 2 diabetes drug lixisenatide suggest that the treatment may…
GRAND RAPIDS, Mich. (March 6, 2024) — Van Andel Institute’s free Public Lecture Series returns March 20. This year’s lineup tackles topics such as cancer and nutrition,…
LONDON (Feb. 23, 2024) — Cure Parkinson’s and Van Andel Institute are delighted to announce funding for a Phase 2 clinical trial…
A “blockbuster” weight loss medication hailed as the “2023 Breakthrough of the Year” by Science also may have game-changing implications for Parkinson’s…
Collaboration, innovation and robust science are a powerful combination, one that drives discoveries aimed at improving health for generations to come. The era of siloed…
GRAND RAPIDS, Mich. (Nov. 14, 2023) — A first-of-its-kind study has identified overactive inflammation and loss of critical protection mechanisms in the brain as potential…